Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study [0.03%]
有关重度斑秃的一项为期24周的多中心真实世界研究：利特昔替尼的效果如何？
Michela Starace,Luca Rapparini,Francesca Pampaloni et al.
Michela Starace et al.
Background: Ritlecitinib, an oral selective inhibitor of Janus kinase 3 and the TEC family of kinases, has recently been approved for the treatment of severe alopecia areata, but real-world data are still limited. ...
Jaime Piquero-Casals,Clémence Bertold,Agustín Alomar et al.
Jaime Piquero-Casals et al.
Background: Vitiligo is a multi-factorial autoimmune skin disorder often triggered by environmental exposures. Although the exposome has gained attention, no systematic review has fully assessed its role in vitiligo. ...
Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study [0.03%]
UCARE PREVALENCE-D研究中与症状性皮肤划痕症相关的因素
Kanokvalai Kulthanan,Jonathan A Bernstein,Michael Rudenko et al.
Kanokvalai Kulthanan et al.
Background and objective: Symptomatic dermographism (SD), the most common chronic inducible urticaria subtype, manifests as strip-shaped, pruritic wheals after skin friction. Conclusive data on its associated factors are ...
Religious and Cultural Considerations for the Dermatologic Care of Muslim Communities: A Narrative Review of Patient-Centered Strategies [0.03%]
从以患者为中心的角度审视针对穆斯林社区皮肤病诊疗的文化和宗教影响：叙述性回顾
Yasser M Almansour,Ferdos Abdulkader,Deena Abdel-Gadir et al.
Yasser M Almansour et al.
Muslim patients may participate in religious and cultural practices that can affect their dermatologic health and influence their preferences regarding care and treatment. In this narrative review, we explore these topics and present cultur...
Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis [0.03%]
伊科特罗克宁拉：用于治疗银屑病的口服白细胞介素-23受体拮抗肽
César Ferreira,Tiago Torres
César Ferreira
Psoriasis is a chronic, immune-mediated inflammatory disease with substantial impact on quality of life. While biologic therapies targeting interleukin (IL)-23 and IL-17 have set new efficacy and safety benchmarks, currently available oral ...
Effectiveness of Systemic Treatments for Atopic Dermatitis in the Head-and-Neck-Area: A Systematic Review and Meta-analysis [0.03%]
针对头颈部特应性皮炎系统治疗有效性的系统评价和网络 meta 分析
Elizabeth Munkebjerg Stevens,Kirstine Vester-Glowinski,Lone Skov et al.
Elizabeth Munkebjerg Stevens et al.
Background: Involvement of the head-and-neck area in atopic dermatitis (AD) is common, associated with reduced quality of life, and suggested as an independent criterion for moderate-to-severe AD. The effectiveness of sys...
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment [0.03%]
定义汗腺炎的中度疾病及进展：专家框架解锁及时治疗机会窗口
Antonio Martorell,John R Ingram,Christopher J Sayed et al.
Antonio Martorell et al.
The concept of a therapeutic window of opportunity, defined as the period from symptom onset during which treatment initiation yields the most favorable patient outcomes, is applied in routine clinical practice across a range of inflammator...
Mastering the Use of Systemic JAK Inhibitors for Atopic Dermatitis: A Dermatologist's Practical Guide [0.03%]
掌握系统性JAK抑制剂治疗特应性皮炎：皮肤科医师实用指南
Ahmad Jalili,Sofia Labbouz,Melinda Gooderham et al.
Ahmad Jalili et al.
Atopic dermatitis (AD) is one of the most frequent conditions treated by dermatologists. The therapeutic options for moderate-to-severe AD are rapidly expanding with the introduction of biologics and Janus kinase inhibitors (JAKis). There a...
Milan van Ammers,Alvin H Chong
Milan van Ammers
Solid organ transplant recipients (SOTRs) experience a significantly elevated risk of skin cancer, primarily due to the immunosuppressive and carcinogenic effects of anti-rejection medications. Both incidence and mortality are substantially...
A Matched Pairs Analysis of GLP-1 Receptor Agonists in Hidradenitis Suppurativa [0.03%]
人胰高糖素样肽-1受体激动剂治疗汗腺炎的配对分析
Thao Lam,Jeffrey N Li,Hadar Lev-Tov
Thao Lam